📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding ENVX

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Steve Cohen Point72 Asset Management	696.7K	$3.6M	0.00%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific → Stable 4 quarters analysed

Q2 2025

Confident Specific

Management repeatedly used phrases like 'great progress,' 'true commercialization phase,' and 'the only battery I know of that can meet all those requirements.' They gave concrete numbers (revenue $7.5M, gross margin 31%, 900 Wh/L) and described specific customer engagements (two smartphone OEMs, eyewear company).

Q3 2025

Confident Specific

Management expressed strong confidence in technology and execution (e.g., 'I'm very confident', 'tremendous progress') while providing specific milestones (Polaris validation, Honor design iteration, Q4 shipment target). Tone balanced by acknowledgment of typical qualification timelines and a minor chemistry tweak, reflecting measured optimism.

Q4 2025

Confident Specific

The tone is confident and detailed, with management providing specific metrics on cycle life testing results, revenue growth, and product qualification pathways. However, they acknowledge the 0.7C accelerated test as a key gating item and discuss multiple pathways to resolution, indicating cautious optimism rather than pure confidence.

Q1 2026 latest

Confident Specific

Raj Talluri repeatedly cited concrete metrics (90% yields in most zones, 80% in Zone 1, 26.3% non-GAAP gross margin, 49% revenue growth, 300 cycles for drone cell, 60% SiC in MX1) and demonstrated progress in a video. Language like 'encouraged by the substantial progress', 'meaningful step', and 'validates our ability' conveys strong conviction.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is materially stronger after this call. Management provided multiple discrete commercialization proof points: first revenue from smart eyewear production, a new drone cell with competitive specs, and a clear pathway to smartphone qualification with the removal of the gating 0.7C test. The Korea pipeline growth ($130M+) and the launch of AI-2 with 20% energy density improvement show technology execution. The main watch items for next quarter are: (a) completion of the 0.2C cycle test at Honor and decisions on system-level deployment, (b) initial shipment volumes of AI-1 smart eyewear cells, and (c) conversion of the drone pipeline into purchase orders. The balance sheet ($582M cash) provides ample runway, so near-term dilution risk is low. Thesis has shifted from 'technology validation' to 'commercial ramp execution' – a positive evolution.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🔒

Premium Feature

AI-generated 10-section company profile — business model, financials, strengths, risks & management quality

Upgrade to Premium

Already a member? Log in

📐

3-Statement Financial Model

Bear / Base / Bull projections · DCF fair value · Reverse-DCF

Open Model →

🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →

📊 MIXED Enovix Q1 rev $7.6M, silicon anode batteries for smart eyewear and drones

Revenue & Profitability

Q1 2026 revenue was $7.6 million, above guidance and up 49% year-over-year. Non-GAAP gross margin was 26.3% (sixth consecutive positive quarter). Non-GAAP loss from operations was $28.8 million, better than the $29-$32 million guidance range. Non-GAAP net loss per share was $0.14. Adjusted EBITDA was -$20.3 million. Cash, equivalents, restricted cash, and marketable securities totaled $582.7 million. Q2 2026 guidance: revenue $8-$9 million, non-GAAP loss from operations $29-$32 million, non-GAAP net loss per share $0.13-$0.17.

Outlook

Management sees strong industry demand for high-performance silicon anode batteries, particularly in rapidly expanding drone and defense markets where supply of Western capacity falls short of demand. The smart eyewear battery market is expected to exceed $1 billion by the end of the decade. In smartphones, OEMs are moving toward silicon anode-specific qualification standards, which management believes will accelerate commercialization. Macro headwinds such as memory cost inflation are noted but not materially affecting Enovix at current low volumes.

Growth Drivers

Key growth levers include smart eyewear (50,000 units planned for 2026, millions expected in 2027), drone and defense applications (pipeline exceeds $130 million, over 60% from drones), and smartphone qualification with Honor (targeted system-level deployment in H2 2026, broader commercial launch in 2027). The MX1 drone battery (360 Wh/kg) launched at Michigan Defense Expo, and AI-2 for smart eyewear (20% higher energy density) will sample in Q2 2026. The company is also winning new design wins in sub-C munitions and industrial markets.

Balance Sheet & CapEx

Capital expenditure payments in Q1 2026 were $3.2 million, below guidance due to timing. Q2 2026 CapEx is guided at $9-$13 million, including deferred payments and initial investments for capacity expansion in Korea. The company has multiple empty buildings in its Nonsan facility for future scaling. Management is adding equipment to an existing building and plans methodical expansion as demand materializes.

Margins

Non-GAAP gross margin was 26.3% in Q1 2026, the sixth consecutive quarter of positive gross profit on both GAAP and non-GAAP bases. The cost structure is dominated by materials; direct labor and variable overhead are small percentages as volume scales. Management expects future margin improvement through bill of materials cost reduction and manufacturing efficiency gains. Operating expenses remain elevated as the company invests in customer qualifications and production readiness.

Key Risks

Risks flagged include qualification timeline uncertainties (0.7C test removal helps but cycle life testing at 0.2C takes longer), yield improvement challenges in Zone 1 dicing (currently ~80% step-level yield), and the need for broad industry alignment on silicon anode-specific testing standards. Low-temperature power performance (freezing test) is an ongoing concern with silicon batteries. Additionally, smartphone unit volumes may be lower this year due to broader market conditions, though not a near-term impact for Enovix.

Generated by AI · Q1 2026 results · Not investment advice

🔒

Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free Account Log In

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to Premium Create Free Account

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-08-12

Q2 2026 saw strong progress across all target markets, with revenue up 21% year-over-year and key milestones achieved in smartphone battery qualification, smart eyewear commercialization, and drone/defense pipeline growth. Gross margins remain positive, and manufacturing yields improved.

Q1 2026 Q1 2026 2026-05-13

Q1 2026 saw strong revenue growth, improved manufacturing yields, and key customer alignments for silicon anode batteries. Smart eyewear and drone markets are ramping, with smartphone field testing and broader commercialization targeted for 2027.

Q4 2025 Q4 2025 2026-02-25

Revenue grew 38% year-over-year to $31.8M in 2025, driven by defense and industrial shipments, with smart eyewear and smartphone commercialization progressing. Strong liquidity of $621M supports expansion, while cycle life testing remains a key hurdle for smartphone qualification.

Q3 2025 Q3 2025 2025-11-05

Q3 2025 revenue grew 85% year-over-year to $8M, with a 21% non-GAAP gross margin and $648M in liquidity. The AI1 smartphone battery achieved industry-leading validation, and key programs with Honor and other OEMs are on track for 2026 launches.

Q2 2025 Q2 2025 2025-07-31

Q2 revenue surged 98% year-over-year to $7.5M, with gross margin turning positive at 31%. The AI-1 battery platform is being sampled to major OEMs, and Fab 2 is ramping up production. Capital raised via warrants supports expansion, but full Fab 2 build-out will require more funding.

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to Premium Create Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.